Bicycle Therapeutics (BCYC)
undefined
undefined%
At close: undefined
13.73
-0.52%
After-hours Dec 13, 2024, 07:40 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 26.98M 14.46M 11.70M 10.39M 13.80M 7.14M 2.06M -
Cost of Revenue 6.47M 3.69M 44.88M 33.15M 25.54M 20.76M 11.87M 269.29K
Gross Profit 20.51M 10.78M -33.18M -22.76M -11.74M -13.63M -9.81M -269.29K
Operating Income -189.95M -116.65M -65.62M -51.96M -26.30M -21.75M -16.21M -13.49M
Interest Income 14.00M 5.76M 120.00K 683.00K 814.00K 169.00K 50.00K 8.00K
Pretax Income -179.21M -114.24M -68.48M -51.73M -30.86M -22.24M -16.28M -13.53M
Net Income -180.66M -112.72M -66.82M -51.01M -30.61M -21.85M -16.26M -13.51M
Selling & General & Admin 59.83M 49.51M 32.44M 29.20M 14.56M 8.12M 6.41M 3.45M
Research & Development 156.50M 81.61M 44.88M 33.15M 25.54M 20.76M 11.87M 9.77M
Other Expenses - - - - -5.38M -665.00K -119.00K -
Operating Expenses 216.92M 131.12M 77.31M 62.35M 40.10M 28.88M 18.27M 13.22M
Interest Expense 3.26M 3.34M 2.98M 457.00K - - - -
Selling & Marketing Expenses - - - - - - - -325.11K
Cost & Expenses 216.92M 131.12M 77.31M 62.35M 40.10M 28.88M 18.27M 13.49M
Income Tax 1.46M -1.52M -1.66M -724.00K -254.00K -396.00K -23.00K -20.94K
Shares Outstanding (Basic) 35.59M 29.66M 25.06M 19.15M 11.05M 13.29M 13.29M 17.70M
Shares Outstanding (Diluted) 35.59M 29.66M 25.06M 19.15M 11.05M 13.29M 13.29M 17.70M
EPS (Basic) -5.08 -3.8 -2.67 -2.66 -2.77 -1.64 -1.22 -0.76
EPS (Diluted) -5.08 -3.8 -2.67 -2.66 -2.77 -1.64 -1.22 -0.76
EBITDA -183.40M -112.96M -64.08M -50.39M -30.03M -21.49M -15.88M -13.26M
Depreciation & Amortization 6.55M 3.69M 1.41M 1.29M 963.97K 710.80K 335.56K 269.29K